1 / 14

TENS: Is it effective in reducing spasticity in Multiple Sclerosis?

TENS: Is it effective in reducing spasticity in Multiple Sclerosis? . The Ayrshire Multiple Sclerosis Service. Caledonian University, Glasgow. The Multiple Sclerosis Society. Linda Miller Senior Physiotherapist. TENS.

RoyLauris
Télécharger la présentation

TENS: Is it effective in reducing spasticity in Multiple Sclerosis?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. TENS: Is it effective in reducing spasticity in Multiple Sclerosis? The Ayrshire Multiple Sclerosis Service. Caledonian University, Glasgow. The Multiple Sclerosis Society. Linda Miller Senior Physiotherapist

  2. TENS • Transcutaneuos Electrical Nerve Stimulation: Electrical stimulation of low intensity, high frequency with short pulse widths selectively stimulates large diameter (Group II), mechanosensative surface nerve endings. • Mechanisms of action: segmental inhibition, release of endogenous opiods, physiological blocking, placebo.

  3. Spasticity & TENS • Evidence of change in neurophysiological measures post TENS. • Reduction in spasticity in stroke & SCI. • Limited research in MS. • Clinical experience of reduction in spasm.

  4. Aims of the study • To determine whether TENS was effective in reducing spasticity in Multiple Sclerosis. • To determine whether TENS was effective for muscle spasm or pain associated with spasticity. • To determine whether application time has an impact on the overall effectiveness of TENS. • To establish protocols for future studies

  5. Study Design • 32 patients from Ayrshire MS service. • Repeated crossover design. Subjects randomly assigned 2 groups • All subjects used TENS for 2 weeks, 60 min per day and for 2 weeks, 8 hrs per day. • Single blind (assessor). • TENS 100Hz, 0.125ms, continuous pulse over quadriceps muscle.

  6. Study Design

  7. Outcome Measures • Demographic data • Global Spasticity Score(Ash+PTR+ Clonus) • Modified Penne Spasm Score • Visual Analogue Score • Compliance diary • Questionnaire

  8. Data Analysis • A 2 sample T - test was used to check the comparability of the demographic & baseline variables of the 2 groups (Mann-Whitney:not normal). • A 3-factor ANOVA(GSS) used to establish that there was no difference between 2 groups. • A paired Wilcoxin was performed on the before & after data (GSS,PSS,VAS) from both groups for 60 min & 8 hrs.

  9. Results 1 • No significant difference between the 2 groups for baseline & demographic data • No sig diff between the groups (p=0.765) • No sig diff in the GSS following TENS (60 min & 8hrs) and in the PSS & VAS following TENS (60 min)

  10. Results 2: However! • Mean scores reduced post TENS, with scores reducing following 8hrs >60min TENS. • Significant reduction in PSS & VAS following TENS (8hrs) p0.05. • Wide variability in all scores : more subjects with scores reduced after 8hrs:60min TENS.

  11. Changes in GSS, PSS & VAS post TENS

  12. Questionnaire Results • The majority of subjects felt TENS had reduced symptoms (88% for spasm). • 72% reported benefits lasting lasting 2-3 days after stopping TENS. • 81% indicated they would continue to use TENS. Most preferred to use <8 hrs • Long term follow up TENS(9 - 21mths) 56% still using.

  13. Conclusion • No statistically significant reductions in spasticity although the majority of subjects demonstrated clinically significant reductions. • TENS is most effective for spasm & pain associated with spasticity. • TENS is more effective when used for longer applications. • TENS is well tolerated and easy to use.

  14. Future ImplicationsThe potential for symptom reduction, combined with reduced medication-related complications and costs makes TENS a treatment worth considering in the overall management of people with mild to moderate spasticity in Multiple Sclerosis.

More Related